Explore
Why vaccines to HIV, HCV and Malaria have so far failed - Challenges to developing vaccines against immunoregulating pathogens
0 Ungluers have
Faved this Work
Login to Fave
Despite continuous progress in the development of anti-viral and anti-bacterial/parasite drugs, the high cost of medicines and the potential for re-infection, especially in high risk groups, suggest that protective vaccines to some of the most dangerous persistent infections are still highly desirable. There are no vaccines available for HIV, HCV and Malaria, and all attempts to make a broadly effective vaccine have failed so far. In this Research Topic we look into why vaccines have failed over the years, and what we have learn from these attempts. Rather than only showing positive results, this issue aims to reflect on failed efforts in vaccine development. Coming to understand our limitations will have theoretical and practical implications for the future development of vaccines to these major global disease burdens.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 146 times via unglue.it ebook links.
- 11 - epub (CC BY) at Unglue.it.
- 8 - epub (CC BY) at Unglue.it.
- 49 - mobi (CC BY) at Unglue.it.
- 47 - epub (CC BY) at Unglue.it.
- 25 - pdf (CC BY) at Unglue.it.
Keywords
- Genetics
- HCV
- HIV
- immunology
- Infectious Disease
- Influenza
- Malaria
- medicine
- Vaccine
Links
DOI: 10.3389/978-2-88919-966-2Editions